Literature DB >> 1947673

Relation between serological data at the time of biopsy and renal histology in lupus nephritis.

J C Nossent1, S C Henzen-Logmans, T M Vroom, V Huysen, J H Berden, A J Swaak.   

Abstract

As autoantibodies are thought to participate in the pathogenesis of renal inflammation in systemic lupus erythematosis (SLE) we investigated associations between serological markers of disease activity in SLE and the activity of renal histopathological lesions in thirty-five patients with lupus nephritis (LN). We found the following prevalence of serum auto-antibodies in LN: IgG antinuclear antibodies (ANA) 100%, IgM ANA 69%, IgA ANA 60%, IgG anti-dsDNA 60%, IgM anti-dsDNA 71%, IgA anti-dsDNA 60%, anti-RNP 20%, anti-Sm 14%, anti-SSA 31%, anti-SSB 14%, anti-histone 37%, anti-cardiolipin 80% and antibody to ribosomal protein (anti-P) 6%. No correlation was found between serological parameters and the WHO-classification of biopsies. The activity-index of histological lesion, assessed according to the NIH-renal histology scoring system, correlated with IgM ANA and IgM anti-dsDNA titers. Of all the specific features of histological renal inflammation, glomerular proliferation showed the best overall correlation with serological parameters of disease activity. Anticardiolipin antibodies were correlated with overall disease activity, but not with renal histological activity. Thus, serological markers of disease activity did not adequately reflect the amount of renal inflammation in LN and cannot replace renal biopsy as a diagnostic tool.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1947673     DOI: 10.1007/bf00291150

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  40 in total

1.  Lupus nephritis: a clinical and pathologic study based on renal biopsies.

Authors:  R C MUEHRCKE; R M KARK; C L PIRANI; V E POLLAK
Journal:  Medicine (Baltimore)       Date:  1957-02       Impact factor: 1.889

2.  NIH conference. Systemic lupus erythematosus: evolving concepts.

Authors:  J L Decker; A D Steinberg; J L Reinertsen; P H Plotz; J E Balow; J H Klippel
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

3.  Low avidity antibodies to double stranded DNA in systemic lupus erythematosus: a longitudinal study of their clinical significance.

Authors:  J C Nossent; V Huysen; R J Smeenk; A J Swaak
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

4.  Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy.

Authors:  G S Hill; N Hinglais; F Tron; J F Bach
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

5.  Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus.

Authors:  P J Maddison; M Reichlin
Journal:  Arthritis Rheum       Date:  1979-08

6.  Low avidity antibodies to dsDNA as a diagnostic tool.

Authors:  J C Nossent; V Huysen; R J Smeenk; A J Swaak
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103

7.  Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.

Authors:  A B Magil; H S Ballon; V Chan; D S Lirenman; A Rae; R A Sutton
Journal:  Medicine (Baltimore)       Date:  1984-07       Impact factor: 1.889

8.  Lupus nephritis. Clinical course as related to morphologic forms and their transitions.

Authors:  D S Baldwin; M C Gluck; J Lowenstein; G R Gallo
Journal:  Am J Med       Date:  1977-01       Impact factor: 4.965

9.  Association between lupus psychosis and anti-ribosomal P protein antibodies.

Authors:  E Bonfa; S J Golombek; L D Kaufman; S Skelly; H Weissbach; N Brot; K B Elkon
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

10.  Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod.

Authors:  K S Kant; V E Pollak; A Dosekun; P Glas-Greenwalt; M A Weiss; H I Glueck
Journal:  J Lab Clin Med       Date:  1985-01
View more
  7 in total

1.  Long-term clinical course in acute crescentic glomerulonephritis.

Authors:  D Bach; K Hauser; B Grabensee
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

2.  Value of anticardiolipin antibodies for monitoring disease activity in systemic lupus erythematosus and other rheumatic diseases.

Authors:  F Buttgereit; T Grünewald; W Schüler-Maué; G R Burmester; F Hiepe
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

3.  Low-Level Proteinuria in Systemic Lupus Erythematosus.

Authors:  Alice Chedid; Giovanni M Rossi; Francesco Peyronel; Steven Menez; Mohamed G Atta; Serena M Bagnasco; Lois J Arend; Avi Z Rosenberg; Derek M Fine
Journal:  Kidney Int Rep       Date:  2020-09-18

Review 4.  Autoantibodies in systemic lupus erythematosus.

Authors:  Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2011-12-23       Impact factor: 3.651

5.  Urinary Albumin Levels are Independently Associated with Renal Lesion Severity in Patients with Lupus Nephritis and Little or No Proteinuria.

Authors:  Jin Ding; Zhaohui Zheng; Xueyi Li; Yuan Feng; Nan Leng; Zhenbiao Wu; Ping Zhu
Journal:  Med Sci Monit       Date:  2017-02-03

6.  Comparison Study on the Effect of Treatment Decision Based on Renal Biopsy and Clinical Symptoms in the Outcome of Patients with Recurrent Lupus Nephritis.

Authors:  Hadi Karimzadeh; Shokrollah Hasani; Zahra Sayedbonakdar; Ali Mehrabi Koushki
Journal:  Adv Biomed Res       Date:  2017-11-30

7.  The potential diagnostic utility of coexpression of Ki-67 and P53 in the renal biopsy in pediatric lupus nephritis.

Authors:  Mahtab H Rahbar; Maryam R Rahbar; Nyousha Mardanpour; Sourena Mardanpour
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-12-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.